Infographic: Building oligos with phosphoramidites

Oligonucleotides are short strands of DNA or RNA used in a variety of diagnostic kits and therapeutic applications. This infographic explores the role of phosphoramidites as essential building blocks in chemical synthesis of oligonucleotide and their considerations for therapeutic and diagnostic applications.

Access the infographic to learn about:

  • Phosphoramidites basics
  • Phosphoramidite attributes and applications
  • Phosphoramidite considerations for diagnostic development
  • Phosphoramidite considerations for therapeutic development
  • - Select -
  • Afghanistan
  • Albania
  • Algeria
  • Andorra
  • Angola
  • Antigua and Barbuda
  • Armenia
  • Aruba
  • Austria
  • Azerbaijan
  • Bahrain
  • Belarus
  • Belgium
  • Benin
  • Bosnia and Herzegovina
  • Botswana
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cameroon
  • Canary Islands
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Comoros
  • Congo
  • Congo (Democratic Republic of)
  • Cote Dlvoire (Ivory Coast)
  • Croatia (Hrvatska)
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Egypt
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Finland
  • France
  • France Metropolitan
  • Gabon
  • Gambia
  • Georgia
  • Germany | Deutschland
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Guinea
  • Hungary
  • Iceland
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Jordan
  • Kazakhstan
  • Kenya
  • Kuwait
  • Kyrgyzstan
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macedonia
  • Madagascar
  • Malawi
  • Mali
  • Malta
  • Mauritania
  • Mauritius
  • Mayotte
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Netherlands
  • Niger
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Palestine
  • Poland
  • Portugal
  • Qatar
  • Reunion
  • Romania
  • Russia | Россия
  • Rwanda
  • S. Georgia and S. Sandwich Isls.
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Slovak Republic
  • Slovenia
  • Somalia
  • South Africa
  • Spain
  • St. Helena
  • Svalbard and Jan Mayen Islands
  • Swaziland
  • Sweden
  • Switzerland
  • Syria
  • Tajikistan
  • Tanzania
  • Togo
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • Uzbekistan
  • Vatican City State (Holy See)
  • Virgin Islands (British)
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
What type of oligos are you working on for oligo therapeutics development? (Check all that apply)
Would you like to discuss phosphoramidites for oligo manufacturing with our representative?

I would like Thermo Fisher Scientific (including its affiliates) to add me to a list to receive information about events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:

 

I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com

I acknowledge Thermo Fisher Scientific (including its affiliates) willl process my Personal Information according to its Privacy Policy, which includes information about my rights.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.